GlaxoSmithKline has sold a plant in India once used to make the recalled heartburn drug Zantac for only a fraction of its initial cost.…
A federal judge has cleared the way for direct filing in Zantac lawsuits through the use of an expedited Short Form Complaint.…
Plaintiffs have filed two amended class action lawsuits in Zantac cancer litigation, seeking for manufacturers to pay for economic losses and medical monitoring for those who took the recalled heartburn drug.…
Two new studies appear to strengthen the science indicating Zantac’s active ingredient, ranitidine, converts to the cancer-causing chemical NDMA duriing digestive processes.…
Plaintiffs involved in 41 federal Zantac lawsuits say their cases were wrongly removed to federal court, and are asking the Zantac MDL judge to remand their cases back to California state courts where they originated.…
Plaintiffs say they plan to show how numerous types of cancer are linked to the side effects of Zantac, which has been recalled due to high levels of the toxic chemical, NDMA.…
Zantac lawsuits filed against generic manufacturers, renovators and retailers have been dismissed by a federal judge, leaving only brand-name manufacturers to face claims the recalled heartburn drug can cause cancer.…
A new study links NDMA found in Zantac to a higher risk of gastrointestinal cancers than other heartburn drugs.…
A new study reports to have found how Zantac changes into NDMA, which has been linked to an increased risk of cancer.…
NDMA appears to be an inherent side effect of Zantac chemical interactions, meaning the cancer-causing chemicals have been in the popular heartburn drug since it was first put on the market.…
